Bottom line
Is FSKLX a good fund? The bottom line
FSKLX is an index international stock mutual fund from Fidelity.
It charges 0.16% — about $16 a year on every $10,000 invested, cheaper than 95% of international stock funds we track.
It returned +1.2% over one year, +1.5% a year over five years, +3.5% a year over ten (as of Dec 31, 2025, per its prospectus).
With $7.9 billion in net assets and 132 holdings, its largest position is Oversea-chinese Bkg Corp Ltd (2.1%) and the top 10 make up 19.2% of the portfolio.
What stands out
- Low cost: cheaper than 95% of international stock peers
What to watch
- 5-year return in the bottom quarter of its category
Updated Nov 19, 2026
What FSKLX invests in
Fidelity SAI International Low Volatility Index Fund seeks to provide investment results that correspond to the total return of low volatility foreign stocks.
Normally investing at least 80% of assets in equity securities included in the Fidelity International Low Volatility Focus IndexSM. The Fidelity International Low Volatility Focus Index SM reflects the performance of a broad range of equities across developed markets that in the aggregate have lower volatility relative to the broader foreign developed equity markets. The universe of equities for consideration in the index consists of the largest developed international equities based on float-adjusted market cap and certain liquidity and investability requirements. The Fidelity International Low Volatility Focus Index SM is constructed using Fidelity's rules-based proprietary index methodology. Equities are ranked and given a composite score based on two measures of volatility: low 5-year standard deviation of price returns and low 5-year beta. Derivative instruments that provide…
From the fund's prospectus (filed Dec 29, 2025).
FSKLX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| FSKLX | +1.2% | +1.5% | +3.5% |
| International Stock median | +25.5% | +6.4% | +7.6% |
Source: Fund prospectus, as of Dec 31, 2025
What FSKLX costs
On a $10,000 investment, FSKLX's 0.16% expense ratio costs about $16 a year. The prospectus estimates $205 in total costs over 10 years (assuming 5% annual returns). The median international stock fund charges 0.9%.
FSKLX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Oversea-chinese Bkg Corp Ltd | 2.08% |
| 2 | Tokio Marine Holdings Inc | 2.02% |
| 3 | Kyocera Corp | 2.01% |
| 4 | Novartis Ag | 1.99% |
| 5 | Zurich Insurance Group Ag | 1.97% |
| 6 | Shell Plc | 1.95% |
| 7 | Air Liquide Sa | 1.87% |
| 8 | Roche Holding Ag | 1.84% |
| 9 | Gsk Plc | 1.78% |
| 10 | Astrazeneca Plc | 1.73% |
Source: SEC Form N-PORT, period ended Jul 31, 2026
The top 10 make up 19.2% of the fund. See all top 25 holdings and asset mix →